These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27562715)

  • 1. Short-chain C6 ceramide sensitizes AT406-induced anti-pancreatic cancer cell activity.
    Zhao X; Sun B; Zhang J; Zhang R; Zhang Q
    Biochem Biophys Res Commun; 2016 Oct; 479(2):166-172. PubMed ID: 27562715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The small-molecule IAP antagonist AT406 inhibits pancreatic cancer cells in vitro and in vivo.
    Jiang Y; Meng Q; Chen B; Shen H; Yan B; Sun B
    Biochem Biophys Res Commun; 2016 Sep; 478(1):293-299. PubMed ID: 27387230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of mTOR as a primary resistance factor of the IAP antagonist AT406 in hepatocellular carcinoma cells.
    Zhen MC; Wang FQ; Wu SF; Zhao YL; Liu PG; Yin ZY
    Oncotarget; 2017 Feb; 8(6):9466-9475. PubMed ID: 28036295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
    Hari Y; Harashima N; Tajima Y; Harada M
    Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: in vitro and in vivo effects of the novel Bcl-2 family inhibitor ABT-737.
    Ishitsuka K; Kunami N; Katsuya H; Nogami R; Ishikawa C; Yotsumoto F; Tanji H; Mori N; Takeshita M; Miyamoto S; Tamura K
    Cancer Lett; 2012 Apr; 317(2):218-25. PubMed ID: 22138435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin.
    Witham J; Valenti MR; De-Haven-Brandon AK; Vidot S; Eccles SA; Kaye SB; Richardson A
    Clin Cancer Res; 2007 Dec; 13(23):7191-8. PubMed ID: 18056200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ionizing radiation sensitizes breast cancer cells to Bcl-2 inhibitor, ABT-737, through regulating Mcl-1.
    Wu H; Schiff DS; Lin Y; Neboori HJ; Goyal S; Feng Z; Haffty BG
    Radiat Res; 2014 Dec; 182(6):618-25. PubMed ID: 25409124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C6 ceramide motivates the anticancer sensibility induced by PKC412 in preclinical head and neck squamous cell carcinoma models.
    Zhu Y; Wang C; Zhou Y; Ma N; Zhou J
    J Cell Physiol; 2018 Dec; 233(12):9437-9446. PubMed ID: 29968910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis.
    Simonin K; N'Diaye M; Lheureux S; Loussouarn C; Dutoit S; Briand M; Giffard F; Brotin E; Blanc-Fournier C; Poulain L
    Apoptosis; 2013 Apr; 18(4):492-508. PubMed ID: 23344663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C6 ceramide sensitizes the anti-hepatocellular carcinoma (HCC) activity by AZD-8055, a novel mTORC1/2 dual inhibitor.
    Liu M; Gu P; Guo W; Fan X
    Tumour Biol; 2016 Aug; 37(8):11039-48. PubMed ID: 26897748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins.
    Tagscherer KE; Fassl A; Campos B; Farhadi M; Kraemer A; Böck BC; Macher-Goeppinger S; Radlwimmer B; Wiestler OD; Herold-Mende C; Roth W
    Oncogene; 2008 Nov; 27(52):6646-56. PubMed ID: 18663354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABT-737 increases tyrosine kinase inhibitor-induced apoptosis in chronic myeloid leukemia cells through XIAP downregulation and sensitizes CD34(+) CD38(-) population to imatinib.
    Airiau K; Mahon FX; Josselin M; Jeanneteau M; Turcq B; Belloc F
    Exp Hematol; 2012 May; 40(5):367-78.e2. PubMed ID: 22240609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C6 ceramide dramatically increases vincristine sensitivity both in vivo and in vitro, involving AMP-activated protein kinase-p53 signaling.
    Chen MB; Jiang Q; Liu YY; Zhang Y; He BS; Wei MX; Lu JW; Ji Y; Lu PH
    Carcinogenesis; 2015 Sep; 36(9):1061-70. PubMed ID: 26116623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal short-chain C6 ceramide induces potent anti-osteosarcoma activity in vitro and in vivo.
    Zhai L; Sun N; Han Z; Jin HC; Zhang B
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):274-80. PubMed ID: 26505795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ordering of ceramide formation, caspase activation, and Bax/Bcl-2 expression during etoposide-induced apoptosis in C6 glioma cells.
    Sawada M; Nakashima S; Banno Y; Yamakawa H; Hayashi K; Takenaka K; Nishimura Y; Sakai N; Nozawa Y
    Cell Death Differ; 2000 Sep; 7(9):761-72. PubMed ID: 11042671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABT-737 sensitizes curcumin-induced anti-melanoma cell activity through facilitating mPTP death pathway.
    Yu T; Chen C; Sun Y; Sun H; Li TH; Meng J; Shi X
    Biochem Biophys Res Commun; 2015 Aug; 464(1):286-91. PubMed ID: 26116776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bcl-2 inhibitor ABT-737 enhances the cisplatin-induced apoptosis in breast cancer T47D cells].
    Chen ZJ; Zhang B; Pan SH; Zhao HM; Zhang Y; Feng WH; Li YY; Cao XC
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):891-5. PubMed ID: 22340096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Bcl-2 or IAP proteins does not provoke mutations in surviving cells.
    Shekhar TM; Green MM; Rayner DM; Miles MA; Cutts SM; Hawkins CJ
    Mutat Res; 2015 Jul; 777():23-32. PubMed ID: 25916945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Opposite Effect of L-kynurenine and Ahr Inhibitor Ch223191 on Apoptotic Protein Expression in Pancreatic Carcinoma Cells (Panc-1).
    Leja-Szpak A; Góralska M; Link-Lenczowski P; Czech U; Nawrot-Porąbka K; Bonior J; Jaworek J
    Anticancer Agents Med Chem; 2019; 19(17):2079-2090. PubMed ID: 30987575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C6 ceramide sensitizes pemetrexed-induced apoptosis and cytotoxicity in osteosarcoma cells.
    Zhu X; Du X; Deng X; Yi H; Cui S; Liu W; Shen A; Cui Z
    Biochem Biophys Res Commun; 2014 Sep; 452(1):72-8. PubMed ID: 25152399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.